These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 537884)

  • 61. Quantitative histophotometry analysing significant inductive and alterative effects of aminoglycoside application (gentamicin, tobramycin, amikacin) upon tubular kidney proteins.
    Heinert G; Wyrobnik J; Scherberich J; Mondorf W; Weber W
    Urol Int; 1982; 37(4):221-35. PubMed ID: 6182668
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Selective growth of resistant variants during incubation of Enterobacteriaceae with four aminoglycosides.
    Nilsson L; Sörén L
    J Antimicrob Chemother; 1986 Sep; 18(3):317-24. PubMed ID: 3771425
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative study of Amikacin (BB-K8) and gentamicin activity in vitro against Proteus rettgeri.
    Pérez-Rodríguez F; Bermúdez RH; de Brau CJ
    Bol Asoc Med P R; 1977 Jul; 69(7):222-6. PubMed ID: 268183
    [No Abstract]   [Full Text] [Related]  

  • 64. Resistance surveillance programs and the incidence of gram-negative bacillary resistance to amikacin from 1967 to 1985.
    Gerding DN; Larson TA
    Am J Med; 1986 Jun; 80(6B):22-8. PubMed ID: 3089003
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Bactericidal activity of aminosides in a static system and in a dynamic model].
    Drugeon HB; Maurisset B; Courtieu AL
    Nouv Presse Med; 1979 Oct; 8(42):3403-6. PubMed ID: 395504
    [No Abstract]   [Full Text] [Related]  

  • 66. Frequency of aminoglycoside 6'-N-acetyltransferase among Serratia species during increased use of amikacin in the hospital.
    Larson TA; Garrett CR; Gerding DN
    Antimicrob Agents Chemother; 1986 Jul; 30(1):176-8. PubMed ID: 3752978
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates.
    Jones RN; Barry AL; Fuchs PC; Gavan TL; Sommers HM; Gerlach EH
    Antimicrob Agents Chemother; 1979 Dec; 16(6):823-8. PubMed ID: 533262
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Stability and antimicrobial activity of gentamicin sulfate, tobramycin sulfate and amikacin sulfate in polypropylene syringes for use in once-daily aminoglycoside therapy.
    Mitrzyk B; Jarco PE; Rybak MJ
    Am J Health Syst Pharm; 1996 Dec; 53(23):2855-9. PubMed ID: 8957347
    [No Abstract]   [Full Text] [Related]  

  • 69. Effects of combinations of clindamycin with gentamicin, tobramycin, and amikacin against Staphylococcus aureus.
    Watanakunakorn C; Glotzbecker C
    J Antimicrob Chemother; 1980 Nov; 6(6):785-91. PubMed ID: 7440469
    [No Abstract]   [Full Text] [Related]  

  • 70. Bactericidal activity of amikacin and gentamicin.
    Shah RM; Heetderks G; Stille W
    Chemotherapy; 1977; 23(4):260-6. PubMed ID: 405182
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Microbiological considerations in the use of tobramycin and related aminoglycosidic aminocyclitol antibiotics.
    Moellering RC
    Med J Aust; 1977 Oct; 2(3 Pt 1 Suppl):4-8. PubMed ID: 600197
    [No Abstract]   [Full Text] [Related]  

  • 72. A broth-disc technique for the assay of antibiotic synergism.
    Meyer M; Hofherr L
    Can J Microbiol; 1979 Nov; 25(11):1232-8. PubMed ID: 120215
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparative in vitro activity of tobramycin and gentamicin on three different media.
    Sandven P; Lassen J; Solberg O; Evandt O
    Chemotherapy; 1980; 26(5):354-60. PubMed ID: 7389429
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin.
    Federspil P; Schätzle W; Tiesler E
    J Infect Dis; 1976 Aug; 134 Suppl():S200-5. PubMed ID: 972282
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synergistic effect of N-formimidoyl thienamycin with gentamicin and amikacin against Streptococcus faecalis.
    Gombert ME; Berkowitz LB; Cummings MC
    Antimicrob Agents Chemother; 1983 Feb; 23(2):245-7. PubMed ID: 6404218
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of the automicrobic system for susceptibility testing of Pseudomonas aeruginosa to gentamicin, tobramycin, and amikacin.
    Woolfrey BF; Lally RT; Ederer MN; Quall CO
    J Clin Microbiol; 1984 Apr; 19(4):502-5. PubMed ID: 6425360
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparative study of the antibacterial activity of amikacin and tobramycin during Pseudomonas pulmonary infection in patients with cystic fibrosis.
    Levy J; Baran D; Klastersky J
    J Antimicrob Chemother; 1982 Sep; 10(3):227-34. PubMed ID: 6815155
    [No Abstract]   [Full Text] [Related]  

  • 78. In vitro evaluation of a new aminoglycoside derivative of kanamycin, a comparison with tobramycin and gentamycin.
    Ries K; Levison ME; Kaye D
    Antimicrob Agents Chemother; 1973 Apr; 3(4):532-3. PubMed ID: 4790607
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of peritoneal dialysis solution on the antimicrobial activity of cephalosporins.
    Appleby DH; John JF
    Nephron; 1982; 30(4):341-4. PubMed ID: 7110465
    [TBL] [Abstract][Full Text] [Related]  

  • 80. UK-18892, a new aminoglycoside: an in vitro study.
    Wise R; Andrews JM
    Antimicrob Agents Chemother; 1978 Aug; 14(2):228-33. PubMed ID: 100050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.